- Actavis to take Allergan name, reflecting brand-drug focus Fidelity - Merger and Acquision News
- Actavis aims to add Allergan CEO to its board: sources Reuters - Markets - Deals
- Actavis to Trim Allergan Executive Ranks OC Business Journal
- Actavis Details Management Structure Post Allergan Acquisition Pharmpro News
- Allergan stock hits record after $66-billion Actavis deal The Daily Pilot - Newport Beach, CA
- Allergan agrees to $66 billion Actavis deal; Valeant walks Reuters: Business
- Actavis, Allergan Could Announce Merger Deal Monday Benzinga.com
- Actavis Enters the Allergan Buy-Out Game as Allergan Fights Valeant's Hostile Bid Pharma Manufacturing - News
- Actavis in talks to buy Allergan for at least $60 billion: Bloomberg Reuters - Markets - Deals
- Valeant ready to raise Allergan bid to at least $200/share Fidelity - Merger and Acquision News
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on INAMED
- Rate INAMED on their payment behavior
- Ask your network about INAMED with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.